Markets
Analyst Slams Tesla’s Performance; Says Focus on Insurance, Robotaxis Is Distraction
Tesla Inc.'s latest first quarter was "one of top debacles" ever seen in 20 years of covering tech stocks on the Street, Wedbush analyst Daniel Ives said on Thursday. The analyst said the company's ...
Two Years Late, the P/C Insurance Market Is Finally Hardening: W.R. Berkley CEO
Two years after the property/casualty insurance market experienced historic catastrophe losses, it is finally showing signs of hardening, said W.R. Berkley Corp.'s president and CEO. W. Robert ...
Rate Increases Bear Fruit During W.R. Berkley’s Q1; Net Investment Income Dips
W.R. Berkley Corp enjoyed solid premium growth in the 2019 first quarter and its reinsurance arm booked encouraging results, with the carrier crediting "further rate improvement" for the positive ...
Alternative Capital Grew Again in 2018 Even as Total Reinsurance Capital Dropped: Willis Re
While total dedicated reinsurance capital dropped in 2018, alternative capital continued its steady rise, according to a report published by Willis Re. Total dedicated reinsurance capital – which ...
Warm Pacific, Weak El Niño Are Soaking Midwest Farms, Slowing Commerce
American farmers raising their fists to the sky this year may be better off directing their ire toward the ocean. Abnormally warm water in the eastern Pacific, along with a weak El Nino along the ...
Aon Combines Construction & Engineering and Inland Marine Teams Into Single Unit
Aon plc announced it has combined its Construction & Engineering and Inland Marine teams into a single, dedicated global unit within its Reinsurance Solutions business. The new Global ...
Allianz Reportedly Considering Bid for Deutsche Bank’s Asset Management Business
Allianz and Amundi are both considering deals to take over Deutsche Bank's asset management unit DWS, sources close to the matter said on Wednesday. Germany's biggest bank is looking at a possible ...
Carcinogen-Tainted Heart Drugs Lead to a Wave of Lawsuits
Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to ...